Results 71 to 80 of about 841 (115)

PROTACs in cancer immunotherapy: a minireview. [PDF]

open access: yesBiochem Soc Trans
J E K, E S CA, E T C, J S G, F M F.
europepmc   +1 more source

Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC Discovery. [PDF]

open access: yesJ Med Chem
Mitrović M   +19 more
europepmc   +1 more source

Methods to accelerate PROTAC drug discovery. [PDF]

open access: yesBiochem J
Osman J   +3 more
europepmc   +1 more source

Tumor microenvironment-targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors. [PDF]

open access: yesSci Adv
Vogt KC   +12 more
europepmc   +1 more source

Precision-engineered PROTACs minimize off-tissue effects in cancer therapy. [PDF]

open access: yesFront Mol Biosci
Shi J   +8 more
europepmc   +1 more source

Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy. [PDF]

open access: yesAutophagy
Rivault A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy